{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T05:15:43Z","timestamp":1738559743817,"version":"3.35.0"},"reference-count":22,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1973,6,1]]},"DOI":"10.1136\/jnnp.36.3.354","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:02:42Z","timestamp":1226350962000},"page":"354-361","source":"Crossref","is-referenced-by-count":14,"title":["Interactions of L-dopa and amantadine in patients with Parkinsonism"],"prefix":"10.1136","volume":"36","author":[{"given":"B.","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Danta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schnieden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Yuill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jama.1956.02960400010003","article-title":"Quantitative measurement of therapy in paralysis agitans","volume":"160","author":"Agate, Jr., F.J.; Doshay, L.J.; Curtis, F.K.","year":"1956","unstructured":"Agate, F. J., Jr., Doshay, L. J., and Curtis, F. K. (1956). Quantitative measurement of therapy in paralysis agitans. Journal of the American Medical Association, 160, 352-354.","journal-title":"Journal of the American Medical Association"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0024-3205(63)90132-2","article-title":"On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method","volume":"7","author":"Anden, N.E.; Roos, B.E.; Werdinius, B.","year":"1963","unstructured":"Anden, N. E., Roos, B. E., and Werdinius, B. (1963). On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method. Life Sciences, 7, 448-458.","journal-title":"Life Sciences"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0022-3565(25)27215-9","article-title":"Absorption, distribution and excretion of amantadine hydrochloride","volume":"150","author":"Bleidner, W.E.; Harmon, J.B.; Hewes, W.E.; Lynes, T.E.; Hermann, E.C.","year":"1965","unstructured":"Bleidner, W. E., Harmon, J. B., Hewes, W. E., Lynes, T. E., and Hermann, E. C. (1965). Absorption, distribution and excretion of amantadine hydrochloride. Journal ofPharmacology and Experimental Therapeutics, 150, 484-490.","journal-title":"Journal ofPharmacology and Experimental Therapeutics"},{"key":"ref_4","first-page":"308","article-title":"Rigidity in extrapyramidal disease","volume":"24","author":"Boshes, B.","year":"1966","unstructured":"Boshes, B. (1966). Rigidity in extrapyramidal disease. Discussion. Journal of Neurosurgery, 24, 308-309.","journal-title":"Discussion. Journal of Neurosurgery"},{"key":"ref_5","first-page":"973","article-title":"L-dopa in idiopathic parkinsonism","volume":"2","author":"Calne, D.B.; Spiers, A.S.D.; Stern, G.M.; Laurence, D.R.; Armitage, P.","year":"1969","unstructured":"Calne, D. B., Spiers, A. S. D., Stern, G. M., Laurence, D. R., and Armitage, P. (1969). L-dopa in idiopathic parkinsonism. Lancet, 2, 973-976.","journal-title":"Lancet"},{"key":"ref_6","first-page":"744","article-title":"L-dopa in postencephalitic parkinsonism","volume":"1","author":"Calne, D.B.; Stern, G.M.; Laurence, D.R.; Sharkey, J.; Armitage, P.","year":"1969","unstructured":"Calne, D. B., Stern, G. M., Laurence, D. R., Sharkey, J., and Armitage, P. (1969). L-dopa in postencephalitic parkinsonism. Lancet, 1, 744-747.","journal-title":"Lancet"},{"key":"ref_7","first-page":"154","article-title":"Amantadine versus L-dopa and amantadine plus L-dopa","volume":"2","author":"Fieschi, C.; Nardini, M.; Casacchia, M.; Tedone, M.E.; Reitano, M.; Robotti, E.","year":"1970","unstructured":"Fieschi, C., Nardini, M., Casacchia, M., Tedone, M. E., Reitano, M., and Robotti, E. (1970). Amantadine versus L-dopa and amantadine plus L-dopa. Lancet, 2, 154-155.","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.2042-7158.1970.tb08486.x","article-title":"The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates","volume":"22","author":"Fletcher, E.A.; Redfern, P.H.","year":"1970","unstructured":"Fletcher, E. A., and Redfern, P. H. (1970). The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates. Journal of Pharmacy and Pharmacology, 22, 957-959.","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"ref_9","first-page":"1086","article-title":"Activity of amantadine","volume":"2","author":"Galegov, G.A.; Pushkarskaya, N.L.; Lavrov, S.V.","year":"1967","unstructured":"Galegov, G. A., Pushkarskaya, N. L., and Lavrov, S. V. (1967). Activity of amantadine. Lancet, 2, 1086-1087.","journal-title":"Lancet"},{"key":"ref_10","first-page":"383","article-title":"Combined treatment of parkinsonism with L-dopa and amantadine","volume":"2","author":"Godwin-Austen, R.B.; Frears, C.C.; Bergmann, S.; Parkes, J.D.; Knill-Jones, R.P.","year":"1970","unstructured":"Godwin-Austen, R. B., Frears, C. C., Bergmann, S., Parkes, J. D., and Knill-Jones, R. P. (1970). Combined treatment of parkinsonism with L-dopa and amantadine. Lancet, 2, 383-385.","journal-title":"Lancet"},{"key":"ref_11","first-page":"165","article-title":"Effects of L-dopa in Parkinson's disease","volume":"2","author":"Godwin-Austen, R.B.; Tomlinson, E.B.; Frears, C.C.; Kok, H.W.L.","year":"1969","unstructured":"Godwin-Austen, R. B., Tomlinson, E. B., Frears, C. C., and Kok, H. W. L. (1969). Effects of L-dopa in Parkinson's disease. Lancet, 2, 165-168.","journal-title":"Lancet"},{"key":"ref_12","first-page":"247","article-title":"L'associazione terapeutica L-dopa amantadina","volume":"16","author":"Gomirato, G.; Perfetti, C.","year":"1970","unstructured":"Gomirato, G., and Perfetti, C. (1970). L'associazione terapeutica L-dopa amantadina. Rivista di Neurobiologia, 16, 247-254.","journal-title":"Rivista di Neurobiologia"},{"issue":"6","key":"ref_13","first-page":"28","article-title":"The treatment of parkinsonism with L-dopa and amantadine","volume":"57","author":"Green, J.","year":"1970","unstructured":"Green, J. (1970). The treatment of parkinsonism with L-dopa and amantadine. Journal of the Florida Medical Association, 57, No. 6, 28-33.","journal-title":"Journal of the Florida Medical Association"},{"key":"ref_14","first-page":"11271129","article-title":"Amantadine in parkinsonism","volume":"1","author":"Hunter, K.R.; Stern, G.M.; Laurence, D.R.; Armitage, P.","year":"1970","unstructured":"Hunter, K. R., Stern, G. M., Laurence, D. R., and Armitage, P. (1970a). Amantadine in parkinsonism. Lancet, 1, 11271129.","journal-title":"Lancet"},{"key":"ref_15","first-page":"566","article-title":"Combined treatment of parkinsonism with L-dopa and amantadine","volume":"2","author":"Hunter, K.R.; Stern, G.M.; Laurence, D.R.; Armitage, P.","year":"1970","unstructured":"Hunter, K. R., Stern, G. M., Laurence, D. R., and Armitage, P. (1970b). Combined treatment of parkinsonism with L-dopa and amantadine. Lancet, 2, 566.","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/bmj.1.5692.331","article-title":"Treatment of parkinsonism with laevo-dopa","volume":"1","author":"Mawdsley, C.","year":"1970","unstructured":"Mawdsley, C. (1970). Treatment of parkinsonism with laevo-dopa. British Medical Journal, 1, 331-337.","journal-title":"British Medical Journal"},{"key":"ref_17","first-page":"259","article-title":"Controlled trial of amantadine hydrochloride in Parkinson's disease","volume":"1","author":"Parkes, J.D.; Zilkha, K.J.; Calver, D.M.; Knill-Jones, R.P.","year":"1970","unstructured":"Parkes, J. D., Zilkha, K. J., Calver, D. M., and Knill-Jones, R. P. (1970). Controlled trial of amantadine hydrochloride in Parkinson's disease. Lancet, 1, 259-262.","journal-title":"Lancet"},{"key":"ref_18","first-page":"542","article-title":"An apparatus for measuring passive resistance to movement of the forearm in man","volume":"37","author":"Schnieden, H.","year":"1969","unstructured":"Schnieden, H. (1969). An apparatus for measuring passive resistance to movement of the forearm in man. British Journal of Pharmacology and Chemotherapy, 37, 542P543P.","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.2042-7158.1970.tb08487.x","article-title":"On the mode of action of amantadine","volume":"22","author":"Str6mberg, U.; Svensson, T.H.; Waldeck, B.","year":"1970","unstructured":"Str6mberg, U., Svensson, T. H., and Waldeck, B. (1970). On the mode of action of amantadine. Journal ofPharmacy and Pharmacology, 22, 959-961.","journal-title":"Journal ofPharmacy and Pharmacology"},{"key":"ref_20","first-page":"299","article-title":"Rigidity in extrapyramidal disease","volume":"24","author":"Webster, D.D.","year":"1966","unstructured":"Webster, D. D. (1966). Rigidity in extrapyramidal disease. Journal of Neurosurgery, 24, suppl. 299-309.","journal-title":"Journal of Neurosurgery"},{"key":"ref_21","first-page":"257","article-title":"Critical analysis of the disability in Parkinson's disease","volume":"5","author":"Webster, D.D.","year":"1968","unstructured":"Webster, D. D. (1968). Critical analysis of the disability in Parkinson's disease. Modern Treatment, 5, 257-282.","journal-title":"Modern Treatment"},{"key":"ref_22","first-page":"325","article-title":"L-dopa and amantadine in the therapy of parkinsonism","volume":"68","author":"Weeth, J.B.; Shealy, C.N.; Mercier, D.A.","year":"1969","unstructured":"Weeth, J. B., Shealy, C. N., and Mercier, D. A. (1969). L-dopa and amantadine in the therapy of parkinsonism. Wisconsin Medical Journal, 68, 325-328.","journal-title":"Wisconsin Medical Journal"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.36.3.354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T16:40:59Z","timestamp":1738514459000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.36.3.354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1973,6,1]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1973,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.36.3.354","relation":{},"ISSN":["0022-3050"],"issn-type":[{"type":"print","value":"0022-3050"}],"subject":[],"published":{"date-parts":[[1973,6,1]]}}}